0001599298-22-000034.txt : 20220426 0001599298-22-000034.hdr.sgml : 20220426 20220426163658 ACCESSION NUMBER: 0001599298-22-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220425 FILED AS OF DATE: 20220426 DATE AS OF CHANGE: 20220426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gayko Urte CENTRAL INDEX KEY: 0001559217 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36866 FILM NUMBER: 22854881 MAIL ADDRESS: STREET 1: C/O PARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics Inc. CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-514-7149 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Summit Therapeutics plc DATE OF NAME CHANGE: 20150219 FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 4 1 wf-form4_165100539719830.xml FORM 4 X0306 4 2022-04-25 0 0001599298 Summit Therapeutics Inc. SMMT 0001559217 Gayko Urte C/O SUMMIT THERAPEUTICS INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 1.93 2022-04-25 4 A 0 400000 A 2032-04-25 Common Stock 400000.0 400000 D The option was granted on April 25, 2022. The shares underlying the option are scheduled to vest in four equal annual installments over four years. Not applicable. /s/ Urte Gayko 2022-04-26